Drugs / Chromium Picolinate
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00332085 | Jan 2006 → Mar 2007 | type 2 diabetes mellitus | Bastyr University | Terminated | No outcome recorded Stop: Enrollment |
| Phase 41 trial | ||||||
| Phase 4 | NCT00283777 | Aug 1998 → Jan 2003 | type 2 diabetes mellitus | Pennington Biomedical Research Center | Completed | No outcome recorded |
| Phase not applicable5 trials · 1 met primary · 1 missed | ||||||
| — | NCT07371169 | Jan 2025 → Jan 2026 | acanthosis nigricans | Uruk University | Completed | No outcome recorded |
| — | NCT00477854 | Apr 2005 → May 2007 | atypical depressive disorder, obesity disorder | Pennington Biomedical Research Center | Completed | No outcome recorded |
| — | NCT00128154 | Jan 2004 → Dec 2005 | metabolic syndrome X, obesity disorder, prediabetes syndrome | National Center for Complementary and Integrative Health (NCCIH) | Completed | Missed primary |
| — | NCT00308451 | Nov 2003 → Apr 2004 | type 2 diabetes mellitus | Nutrition 21, Inc. | Completed | No outcome recorded |
| — | NCT00289354 | Mar 2003 → Nov 2005 | type 2 diabetes mellitus | Nutrition 21, Inc. | Completed | Met primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chromium Picolinate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00332085 ↗ |
| Known as | CrPic | “The objective of this study was to determine the effects of chromium picolinate (CrPic) on glucose metabolism in patients with metabolic syndrome.” PMID 19422140 ↗ Apr 2009 |
| Modality | Other / unclassified | “Chromium is an essential mineral that is used in the breakdown of fats, protein, and carbohydrates.” NCT00128154 ↗ |
| Route | Oral | “Participants in this arm (n=45) will recieve oral Chromium Picolinate 200mcg capsules once daily during the 24-weeks study period.” NCT07371169 ↗ |